Bluejay Diagnostics, Inc. Investment Income, Interest
Bluejay Diagnostics, Inc. (BJDX) reported Investment Income, Interest of $24.83 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-12
- Bluejay Diagnostics, Inc. investment income, interest for the quarter ending 2026-06-30 was $24.83K, a 15.13% decline year-over-year.
- Bluejay Diagnostics, Inc. investment income, interest for the quarter ending 2026-03-31 was $18.86K, a 5.94% increase year-over-year.
- Bluejay Diagnostics, Inc. investment income, interest for the quarter ending 2025-12-31 was $31.54K, a 18.35% decline year-over-year.
- Bluejay Diagnostics, Inc. investment income, interest for the quarter ending 2025-09-30 was $18.96K, a 69.27% decline year-over-year.
- Bluejay Diagnostics, Inc. investment income, interest for fiscal 2025 was $97.56K, a 33.10% decline from fiscal 2024.
- Bluejay Diagnostics, Inc. investment income, interest for fiscal 2024 was $145.82K, a 11.57% decline from fiscal 2023.
- Bluejay Diagnostics, Inc. investment income, interest for fiscal 2023 was $164.90K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $24.83K 10-Q · filed 2026-08-12 | $43.69K 10-Q · filed 2026-08-12 | $75.23K derived: sum of 3 quarters · filed 2026-08-12 | $94.19K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $18.86K 10-Q · filed 2026-05-07 | $50.40K derived: sum of 2 quarters · filed 2026-05-07 | $69.36K derived: sum of 3 quarters · filed 2026-05-07 | $98.62K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $31.54K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $50.50K derived: sum of 2 quarters · filed 2026-03-06 | $79.76K derived: sum of 3 quarters · filed 2026-08-12 | $97.56K 10-K · filed 2026-03-06 |
| 2025-09-30 | $18.96K 10-Q · filed 2025-11-07 | $48.22K derived: sum of 2 quarters · filed 2026-08-12 | $66.02K 10-Q · filed 2025-11-07 | $104.65K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $29.25K 10-Q · filed 2026-08-12 | $47.05K 10-Q · filed 2026-08-12 | $85.69K derived: sum of 3 quarters · filed 2026-08-12 | $147.38K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $17.80K 10-Q · filed 2026-05-07 | $56.43K derived: sum of 2 quarters · filed 2026-05-07 | $118.13K derived: sum of 3 quarters · filed 2026-05-07 | $133.53K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $38.63K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $100.32K derived: sum of 2 quarters · filed 2026-03-06 | $115.73K derived: sum of 3 quarters · filed 2026-03-06 | $145.82K 10-K · filed 2026-03-06 |
| 2024-09-30 | $61.69K 10-Q · filed 2025-11-07 | $77.10K derived: sum of 2 quarters · filed 2025-11-07 | $107.19K 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $15.41K 10-Q · filed 2025-08-07 | $45.50K 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $30.09K 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | $164.90K 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |